| scholarly article | Q13442814 |
| P50 | author | Hiroto Furuta | Q90443925 |
| P2093 | author name string | Kishio Nanjo | |
| Hideyuki Sasaki | |||
| Hiromichi Kawashima | |||
| Masahiro Nishi | |||
| Setsuya Sakagashira | |||
| Tadashi Hanabusa | |||
| Eisaku Matsumoto | |||
| Kazuya Ueda | |||
| Miyoshi Sasahara | |||
| P2860 | cites work | Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines | Q29619317 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 482-485 | |
| P577 | publication date | 2004-02-01 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Uncoupling protein 2 promoter polymorphism -866G/A affects its expression in beta-cells and modulates clinical profiles of Japanese type 2 diabetic patients | |
| P478 | volume | 53 |
| Q33685692 | A common UCP2 polymorphism predisposes to stress hyperglycaemia in severe sepsis |
| Q43243820 | A common polymorphism in the promoter of UCP2 is associated with obesity and hyperinsulenemia in northern Indians |
| Q45016206 | A polymorphism in the promoter of UCP2 gene modulates lipid levels in patients with type 2 diabetes |
| Q83725272 | Angiotensinogen t235 and angiotensin-converting enzyme insertion/deletion polymorphisms associated with the development of posttransplantation diabetes mellitus in renal allograft recipients |
| Q47959866 | Association of UCP2 -866 G/A polymorphism with chronic inflammatory diseases |
| Q60689182 | Association of a common polymorphism in the promoter of UCP2 with susceptibility to multiple sclerosis |
| Q87724713 | Association of the UCP polymorphisms with susceptibility to obesity: case-control study and meta-analysis |
| Q95827500 | Association of uncoupling protein (Ucp) gene polymorphisms with cardiometabolic diseases |
| Q34568272 | Associations between UCP1 -3826A/G, UCP2 -866G/A, Ala55Val and Ins/Del, and UCP3 -55C/T polymorphisms and susceptibility to type 2 diabetes mellitus: case-control study and meta-analysis |
| Q33636568 | Degradation of an intramitochondrial protein by the cytosolic proteasome |
| Q41867351 | Direct metabolic effects of risperidone and olanzapine in Japanese schizophrenic patients. |
| Q45078045 | Free fatty acid-induced beta-cell defects are dependent on uncoupling protein 2 expression |
| Q34974646 | Genetic Variance in Uncoupling Protein 2 in Relation to Obesity, Type 2 Diabetes, and Related Metabolic Traits: Focus on the Functional -866G>A Promoter Variant (rs659366) |
| Q21563435 | Genetic prediction of future type 2 diabetes |
| Q39731784 | Ghrelin inhibits insulin secretion through the AMPK-UCP2 pathway in beta cells |
| Q82741995 | Increased Body Mass Index but Not Common Vitamin D Receptor, Peroxisome Proliferator–Activated Receptor γ, or Cytokine Polymorphisms Confers Predisposition to Posttransplant Diabetes |
| Q30571118 | Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data |
| Q33742128 | Interaction between the UCP2 -866 G>A polymorphism, diabetes, and beta-blocker use among patients with acute coronary syndromes |
| Q80800472 | Interaction between the UCP2-866G/A, mtDNA 10398G/A and PGC1alpha p.Thr394Thr and p.Gly482Ser polymorphisms in type 2 diabetes susceptibility in North Indian population |
| Q37247893 | Interactions between UCP2 SNPs and telomere length exist in the absence of diabetes or pre-diabetes. |
| Q34514392 | Investigation of variants in UCP2 in Chinese type 2 diabetes and diabetic retinopathy |
| Q33578125 | Meta-analysis reveals the association of common variants in the uncoupling protein (UCP) 1-3 genes with body mass index variability |
| Q38246367 | Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart |
| Q47722955 | Mitochondrial uncoupling proteins: subtle regulators of cellular redox signaling |
| Q57316399 | The Human Obesity Gene Map: The 2004 Update |
| Q51360789 | The frequent UCP2 -866G>A polymorphism protects against insulin resistance and is associated with obesity: a study of obesity and related metabolic traits among 17 636 Danes. |
| Q50308475 | The mitochondrial uncoupling-protein homologues |
| Q34087758 | The on-off switches of the mitochondrial uncoupling proteins |
| Q37903726 | The role of uncoupling protein 2 (UCP2) on the development of type 2 diabetes mellitus and its chronic complications |
| Q30445084 | The uncoupling protein 1 gene, UCP1, is expressed in mammalian islet cells and associated with acute insulin response to glucose in African American families from the IRAS Family Study |
| Q53086619 | UCP2 −866G/A and Ala55Val, and UCP3 −55C/T polymorphisms in association with type 2 diabetes susceptibility: a meta-analysis study |
| Q57337116 | Uncoupling Protein 2 Promoter Polymorphism −866G/A, Central Adiposity, and Metabolic Syndrome in Asians* |
| Q34332011 | Uncoupling protein 2 G(-866)A polymorphism: a new gene polymorphism associated with C-reactive protein in type 2 diabetic patients |
| Q33836038 | Uncoupling protein 2 regulates daily rhythms of insulin secretion capacity in MIN6 cells and isolated islets from male mice |
| Q35070365 | Uncoupling proteins, dietary fat and the metabolic syndrome |
| Q37065665 | Uncoupling proteins: role in insulin resistance and insulin insufficiency |
| Q33505454 | Variation in the UCP2 and UCP3 genes associates with abdominal obesity and serum lipids: the Finnish Diabetes Prevention Study |
Search more.